Literature DB >> 12702896

Kuopio 75+ study: does advanced age predict more common use of psychotropics among the elderly?

Sirpa Hartikainen1, Terhi Rahkonen, Hannu Kautiainen, Raimo Sulkava.   

Abstract

The elderly use more psychotropic medication than the general population, and its use has grown during recent decades. The aim of this study was to describe the use of psychotropics in the home-dwelling elderly aged 75 years or older in Finland. This Kuopio 75+ Study is a population-based health survey. A random sample of 700 subjects were drawn from the total population of people aged 75 years or more in January 1998. A geriatrician and a trained nurse carried out clinical examination and interview about the use of medicines for 523 home-dwelling elderly. At least one psychotropic medication was used by 37% of the sample, and 12% were using two or more psychotropics concomitantly. The psychotropic users were older, more often widowed and living alone compared to subjects without psychotropic medication. The probability of psychotropic use increased linearly with age for anxiolytics/hypnotics or antipsychotics, but not for antidepressants. Psychotropics are commonly used in the elderly, particularly among those aged 85 years or more, who are most vulnerable to adverse effects. Careful consideration is needed before prescribing psychotropics to the elderly.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12702896     DOI: 10.1097/00004850-200305000-00007

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  9 in total

1.  Use of psychotropics is high among very old people.

Authors:  Sirpa Hartikainen; Timo Klaukka
Journal:  Eur J Clin Pharmacol       Date:  2003-12-02       Impact factor: 2.953

2.  Sedative load and mortality among residents of long-term care facilities: a prospective cohort study.

Authors:  Heidi T Taipale; J Simon Bell; Helena Soini; Kaisu H Pitkälä
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

3.  Concomitant use of analgesics and psychotropics in home-dwelling elderly people-Kuopio 75 + study.

Authors:  Sirpa Hartikainen; Pekka Mäntyselkä; Kirsti Louhivuori-Laako; Hannes Enlund; Raimo Sulkava
Journal:  Br J Clin Pharmacol       Date:  2005-09       Impact factor: 4.335

4.  Capability for daily activities in old people with rheumatoid arthritis: a population based study.

Authors:  M Kauppi; S Hartikainen; H Kautiainen; K Laiho; R Sulkava
Journal:  Ann Rheum Dis       Date:  2005-01       Impact factor: 19.103

5.  Potentially inappropriate medication use among Finnish non-institutionalized people aged ≥65 years: a register-based, cross-sectional, national study.

Authors:  Saija Leikola; Maarit Dimitrow; Alan Lyles; Kaisu Pitkälä; Marja Airaksinen
Journal:  Drugs Aging       Date:  2011-03-01       Impact factor: 3.923

6.  Use of antipsychotics in older home care patients in Finland.

Authors:  Hanna-Mari Alanen; Harriet Finne-Soveri; Anja Noro; Esa Leinonen
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 7.  A cross-sectional study of psychotropic drug use in the elderly: Consuming patterns, risk factors and potentially inappropriate use.

Authors:  María Isabel Santos-Pérez; Inmaculada Fierro; M Esther Salgueiro-Vázquez; María Sáinz-Gil; Luis H Martín-Arias
Journal:  Eur J Hosp Pharm       Date:  2019-06-11

8.  Decreasing the load? Is a Multidisciplinary Multistep Medication Review in older people an effective intervention to reduce a patient's Drug Burden Index? Protocol of a randomised controlled trial.

Authors:  Helene G van der Meer; Hans Wouters; Rolf van Hulten; Niesko Pras; Katja Taxis
Journal:  BMJ Open       Date:  2015-12-23       Impact factor: 2.692

9.  Psychotropic Polypharmacy in Adults 55 Years or Older: A Risk for Impaired Global Cognition, Executive Function, and Mobility.

Authors:  Gilles Loggia; Elpidio Attoh-Mensah; Kristell Pothier; Rémy Morello; Pascale Lescure; Marie-Laure Bocca; Christian Marcelli; Chantal Chavoix
Journal:  Front Pharmacol       Date:  2020-01-30       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.